Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Sickle Cell Anemia
Sickle cell disease (SCD) is a group of related yet genetically complex hemoglobinopathies. Universal newborn screening (NBS) for SCD is performed in the United States and many other nations. Classical, protein-based laboratory methods are often adequate for the diagnosis of SCD but have specific li...
Enregistré dans:
Auteurs principaux: | Lisa M. Shook, Deidra Haygood, Charles T. Quinn |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c1f70e7f65144aefa23176d0bb39f992 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Variantes de hemoglobina en una población con impresión diagnóstica positiva para hemoglobinopatías en Colombia
par: Romero-Sánchez,Consuelo, et autres
Publié: (2015) -
Sickle Cell Anemia and <i>Babesia</i> Infection
par: Divya Beri, et autres
Publié: (2021) -
Screening for the Sickle Cell Trait in Odisha, India: An Approach to a Major Public Health Burden
par: Basanta Kumar Bindhani, et autres
Publié: (2021) -
Anesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia
par: Parmod K. Bithal, et autres
Publié: (2021) -
In Vitro Red Blood Cell Segregation in Sickle Cell Anemia
par: Viviana Clavería, et autres
Publié: (2021)